News Archive - Page 52 of 62

Estrogen-negative cancers respond to anti-estrogenic therapies

Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice models. Estrogen, a group of female hormones, is known to be involved in cancer progression, especially breast cancer. About 75 % of breast cancers are estrogen-sensitive: they express […]

Estrogen-negative cancers respond to anti-estrogenic therapies Read More »

Perils of not being attractive or athletic in middle school

AIHBA / By Editor

Despite the many changes in school culture since the 1960s, a new study reveals that some things never change: life is harder for middle school students who are not attractive and for those who are not athletic. As children head back to school, the first-of-its-kind longitudinal study by Florida Atlantic University helps to explain why

Perils of not being attractive or athletic in middle school Read More »

Study confirms racial differences in response to prostate cancer treatment

AIHBA / By Editor

A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease. Researchers at Duke Cancer Institute enrolled 50 Black and 50 white men with

Study confirms racial differences in response to prostate cancer treatment Read More »

Research into use of diabetes medication for treatment of metastatic prostate cancer

AIHBA / By Editor

Patients with localised prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of the condition remain high. Until now, the precise mechanism behind the spread of the tumour has not been fully explained. But an international research team headed by MedUni Vienna has succeeded in decoding the

Research into use of diabetes medication for treatment of metastatic prostate cancer Read More »

New approach to target a deadly form of prostate cancer

AIHBA / By Editor

A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer. Using tissue samples and cell models from patients, Joshi Alumkal, M.D., Wicha Family Professor of Oncology and leader of

New approach to target a deadly form of prostate cancer Read More »

New insights into androgen's action could boost battle against prostate cancer

AIHBA / By Editor

Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells — and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers. The findings shed light on how androgens interact with their receptors inside cells to affect gene activity. This

New insights into androgen's action could boost battle against prostate cancer Read More »

Anti-androgen therapy can fuel spread of bone tumors in advanced prostate cancer

AIHBA / By Editor

Dr Bock, under the mentorship of Distinguished Professor Dietmar Hutmacher, from QUT Centre for Biomedical Technologies, has focused her research on bone metastases from breast and prostate cancers. She developed 3D miniature bone-like tissue models in which 3D printed biomimetic scaffolds are seeded with patient-derived bone cells and tumour cells to be used as clinical

Anti-androgen therapy can fuel spread of bone tumors in advanced prostate cancer Read More »

New blood test improves prostate cancer screening

AIHBA / By Editor

Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a study in The Lancet Oncology, which shows that the addition of a novel blood test, the Stockholm3 test, can reduce the number of MRIs performed

New blood test improves prostate cancer screening Read More »

Patients helping researchers to advance treatments for prostate cancer

AIHBA / By Editor

Researchers at Monash University have established one of the world’s largest collections of living tumours from prostate cancer patients, accelerating the testing of new treatments for prostate cancer and leading to faster patient benefit. One of the most common cancers, prostate cancer is also one of the most difficult to study in the laboratory, with

Patients helping researchers to advance treatments for prostate cancer Read More »

Staying young, from the cells on up

AIHBA / By Editor

Researchers at Université de Montréal and McGill University have discovered a new multi-enzyme complex that reprograms metabolism and overcomes “cellular senescence,” when aging cells stop dividing. In their study published today in Molecular Cell, the researchers show that an enzyme complex named HTC (hydride transfer complex) can inhibit cells from aging. “HTC protects cells from

Staying young, from the cells on up Read More »

Estrogen-negative cancers respond to anti-estrogenic therapies

Perils of not being attractive or athletic in middle school

Study confirms racial differences in response to prostate cancer treatment

Research into use of diabetes medication for treatment of metastatic prostate cancer

New approach to target a deadly form of prostate cancer

New insights into androgen's action could boost battle against prostate cancer

Anti-androgen therapy can fuel spread of bone tumors in advanced prostate cancer

New blood test improves prostate cancer screening

Patients helping researchers to advance treatments for prostate cancer

Staying young, from the cells on up

Company

SERVICES

Contact Info

Address

Phone

Email

Phone

Email